Analyzing Bio-Rad Laboratories (NYSE:BIO) & Haemonetics (NYSE:HAE)

Bio-Rad Laboratories (NYSE: BIO - Get Free Report) and Haemonetics (NYSE: HAE - Get Free Report) are both mid-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, dividends, profitability, risk, institutional ownership and earnings. Risk and Volatility Bio-Rad Laboratories has a beta